Malin, the biotechnology investment company backed by the Irish state, paid two of its senior executives more than €3 million each last year.
Kelly Martin, Malin’s chief executive and a former boss of Irish drug company Elan, was paid €3.02 million last year, according to figures published by the company last Friday. He was paid a basic salary of €334,000 and a further €38,000 in benefits. But the company also paid him €2.6 million in...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Get a Business Account for you and your team